FDA Approved: REZVOGLAR KWIKPEN — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved Rezvoglar KwikPEN (insulin glargine-AGLR) from Eli Lilly as a biosimilar insulin glargine via an Original Application. It is indicated for glycemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rezvoglar KwikPen (INSULIN GLARGINE-AGLR)

Snippet

ORIG AP for REZVOGLAR KWIKPEN (INSULIN GLARGINE-AGLR)